Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2015
Home
2015
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
Australian Patent Granted for Use of Midkine for Hair Growth
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
USA Patent Granted for MK Treatment of Heart Failure
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
Appendix 4C – quarterly
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
Cellmid Newsletter February Issue
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
Appendix 4D and Half Year Accounts
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
Broker Meets Biotech Presentation
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
Change of Director’s Interest Notice
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
Company Secretary Appointment/Resignation
November 12, 2019
Published by
Tiffany McMillan
on
November 12, 2019
Categories
Cellmid to present MK at World Congress of Angiogenesis
1
2
3
4
5
6
Next page
